We did detect a significant increase in lymphomas and a decrease in sarcomas due to an Mdm2 haploinsufficiency in two of the genotypes (Mdm2+/−Arf−/−p53−/− and Mdm2+/−Arf+/−p53−/−) studied. This evidence concerns the gene MDM2 and lymphoma.